Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2026-01-09 @ 8:36 AM
Study NCT ID:
NCT06650332
Status:
RECRUITING
Last Update Posted:
2024-10-21
First Post:
2024-10-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Sponsor:
Zhejiang Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AK104-IIT-C-M-0119
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None